Inactive Instrument

Sartorius Stedim Biotech SA Share Price Euronext Paris

Equities

STDM

FR0000053266

Medical Equipment, Supplies & Distribution

End-of-day quote Euronext Paris
- EUR - Intraday chart for Sartorius Stedim Biotech SA

Financials

Sales 2024 * 2.94B 3.14B 262B Sales 2025 * 3.35B 3.58B 299B Capitalization 20.27B 21.67B 1,808B
Net income 2024 * 343M 367M 30.59B Net income 2025 * 459M 491M 40.93B EV / Sales 2024 * 7.66 x
Net Debt 2024 * 2.27B 2.42B 202B Net Debt 2025 * 2.15B 2.3B 192B EV / Sales 2025 * 6.69 x
P/E ratio 2024 *
57.7 x
P/E ratio 2025 *
41.7 x
Employees -
Yield 2024 *
0.36%
Yield 2025 *
0.53%
Free-Float 31.97%
More Fundamentals * Assessed data
Managers TitleAgeSince
Chief Executive Officer 48 26/19/26
Chairman 59 29/07/29
Chief Tech/Sci/R&D Officer 59 29/09/29
Members of the board TitleAgeSince
Director/Board Member 62 29/07/29
Chairman 59 29/07/29
Director/Board Member 67 07/15/07
More insiders
Sartorius Stedim Biotech is a leading provider of cutting-edge equipment and services for the development, quality assurance and production processes of the biopharmaceutical industry. Its integrated solutions covering fermentation, filtration, purification, fluid management and lab technologies are supporting the biopharmaceutical industry around the world to develop and produce drugs safely, timely and economically. For next generation processes, Sartorius Stedim Biotech focuses on single-use technologies and value-added services to meet the rapidly changing technology requirements of the industry it serves. Strongly rooted in the scientific community and closely allied with customers and technology partners, the company is dedicated to its philosophy of turning science into solutions on a daily basis. With its own manufacturing and R&D sites in Europe, North America and Asia and a global network of sales companies, Sartorius Stedim Biotech enjoys a worldwide presence. Its key manufacturing and R&D site is in Germany.
Calendar
More about the company